Martine A. Rothblatt - Mar 28, 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Mar 28, 2023
Transactions value $
-$855,163
Form type
4
Date filed
3/30/2023, 04:30 PM
Previous filing
Mar 28, 2023
Next filing
Mar 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $905K +8K +6153.85% $113.08 8.13K Mar 28, 2023 Direct F1
transaction UTHR Common Stock Sale -$569K -2.6K -31.96% $219.05 5.53K Mar 28, 2023 Direct F1, F2
transaction UTHR Common Stock Sale -$655K -2.98K -53.81% $219.98 2.56K Mar 28, 2023 Direct F1, F3
transaction UTHR Common Stock Sale -$494K -2.24K -87.51% $220.90 319 Mar 28, 2023 Direct F1, F4
transaction UTHR Common Stock Sale -$41.9K -189 -59.25% $221.74 130 Mar 28, 2023 Direct F1, F5
holding UTHR Common Stock 166 Mar 28, 2023 By Spouse
holding UTHR Common Stock 644K Mar 28, 2023 By Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -8K -4% $0.00 192K Mar 28, 2023 Common Stock 8K $113.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $218.395 to $219.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $219.50 to $220.455. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $220.52 to $221.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $221.65 to $221.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.